Skip to main content
Livermore
Livermore
ZHEN

Pitcairn Co

SEC CIK
0000315014
Latest filing
Aug 10, 2026

DXCM holding history

Dexcom Inc in every 13F filed by Pitcairn Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of DXCM by Pitcairn Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−10,399−100.0%Sold outHolders
Q3 202510,399$699.7K0.1%−7,539−42.0%ReducedHolders
Q2 202517,938$1.57M0.1%−3,414−16.0%ReducedHolders
Q1 202521,352$1.46M0.1%−46−0.2%ReducedHolders
Q4 202421,398$1.66M0.1%−215−1.0%ReducedHolders
Q3 202421,613$1.45M0.1%−13,769−38.9%ReducedHolders
Q2 202435,382$4.01M0.2%+2,586+7.9%AddedHolders
Q1 202432,796$4.55M0.3%−4,796−12.8%ReducedHolders
Q4 202337,592$4.66M0.3%−16,491−30.5%ReducedHolders
Q3 202354,083$5.05M0.4%+8,470+18.6%AddedHolders
Q2 202345,613$5.86M0.5%−934−2.0%ReducedHolders
Q1 202346,547$5.41M0.5%−2,216−4.5%ReducedHolders
Q4 202248,763$5.52M0.6%+120+0.2%AddedHolders
Q3 202248,643$3.92M0.4%−398−0.8%ReducedHolders
Q2 202249,041$3.65M0.4%−2,411−4.7%ReducedConverted for a 4-for-1 splitHolders
Q1 202212,863$6.58M0.6%+351+2.8%AddedHolders
Q4 202112,512$6.72M0.4%00.0%UnchangedHolders
Q3 202112,512$6.84M0.5%−758−5.7%ReducedHolders
Q2 202113,270$5.67M0.4%−10.0%ReducedHolders
Q1 202113,271$4.77M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.